title: Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir.
authors.forename: Liviana
authors.initials: L
authors.lastname: Da Dalt
authors.forename: Arianna
authors.initials: A
authors.lastname: Calistri
authors.forename: Chiara
authors.initials: C
authors.lastname: Chillemi
authors.forename: Riccardo
authors.initials: R
authors.lastname: Cusinato
authors.forename: Elisa
authors.initials: E
authors.lastname: Franchin
authors.forename: Cristiano
authors.initials: C
authors.lastname: Salata
authors.forename: Dino
authors.initials: D
authors.lastname: Sgarabotto
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Toscano
authors.forename: Antonio
authors.initials: A
authors.lastname: Gambino
authors.forename: Giorgio
authors.initials: G
authors.lastname: Palù
mesh_terms: D002675:Child, Preschool; D004304:Dosage Forms; D024882:Drug Resistance, Viral; D006801:Humans; D016867:Immunocompromised Host; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000235:genetics; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D009154:Mutation; D009330:Nebulizers and Vaporizers; D053139:Oseltamivir / Q000494:pharmacology*; D058873:Pandemics; D053243:Zanamivir / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D004304:Dosage Forms; D053139:Oseltamivir; D053243:Zanamivir